LEVERONE JASON A. (Chief Financial Officer) sold 1.6% of their position (302.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $898.21 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/23/2026ACC: 0001692747-26-000005
Officer· Chief Financial Officer
Since Oct 2024
-302.00
Net shares
Net seller
$898.21
Total sold
1
Open market trades
0B · 1S
1
Total transactions
302.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−302.00
Price / share
$2.97
Trade value
$898.21
% of position
1.6%
9/21/2026
18.80K→18.50K
Total
Net shares
−302.00
Net value
-$898.21
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/21/2026 | S · Sale | −302.00 | $2.97 | $898.21 | 1.6% | 18.80K | 18.50K |
| Total | −302.00 | -$898.21 | ||||||
Derivative Transactions0
No derivative transactions reported